This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.


Shon Green
Director, Clinical Translation at Altius Institute for Biomedical Sciences, USA


Dr. Green received her training as a cancer biologist at UCSF where she developed and employed preclinical models of cancer to study therapeutic combinations. She utilized these expertise to drive the preclinical development of T cell-based immunotherapies at Eureka Therapeutics Inc., where she successfully guided two novel programs through preclinical proof-of-concept and safety studies to support investigational new drug applications and clinical testing. Currently the Director of Clinical Translation at Altius Institute for Biomedical Sciences, she leads the development of novel genetic and epigenetic editing tools to enhance cellular therapies for cancer and other unmet needs.

Agenda Sessions

  • Engineering supercharged T cells via targeted epigenetic silencing of multiple checkpoint genes